Morris Gabriel S — SEC Form 4 filings
SEC reporting owner CIK 1889967. 10 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-14 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 6 filings — 15,895 shares, $36,572 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 4,500 shares @ $2.23 ($10,042) in Immix Biopharma, Inc., filed 2024-05-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | CFO, President, Director | 10 | 6 legs · 15,895 sh · $36,572 | — | 9 |
Form 4 filings — Morris Gabriel S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Immix Biopharma, Inc. (IMMX) | Option exercise/expiry (X): 156,000 @ $0.80 · Purchase (P): 770 @ $6.58 · Option exercise/expiry (X): 96,000 (derivative) @ $0 · Option exercise/expiry (X): 60,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 2,600 @ $1.97 | EDGAR |
| 2025-06-23 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 340,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 2,225 @ $2.28 | EDGAR |
| 2024-06-21 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 340,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 2,500 @ $2.12 | EDGAR |
| 2024-06-05 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 3,300 @ $1.81 | EDGAR |
| 2024-05-20 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 194,218 · Grant/award (A): 24,141 · Grant/award (A): 24,141 | EDGAR |
| 2024-05-14 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 4,500 @ $2.23 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1889967 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →